An Inactivated Novel Trivalent Vaccine Provides Complete Protection against FAdV-4 Causing Hepatitis-Hydropericardium Syndrome and FAdV-8b/-11 Causing Inclusion Body Hepatitis

<div>Inactivated rFAdV-4-fiber/8b + 11 vaccine induced specific immune responses against FAdV-4, FAdV-8b, and FAdV-11. The antibody responses against FAdV-4, FAdV-8b, and FAdV-11 was evaluated by an indirect ELISA. The mean OD<sub>450</sub> nm absorbance values and standard error of the mean are shown for each group. The dashed line represents the background level of detection.</div>

Transboundary and Emerging Diseases

fig3

Figure 3

Figure 3: An Inactivated Novel Trivalent Vaccine Provides Complete Protection against FAdV-4 Causing Hepatitis-Hydropericardium Syndrome and FAdV-8b/-11 Causing Inclusion Body Hepatitis 

Figure 3 | An Inactivated Novel Trivalent Vaccine Provides Complete Protection against FAdV-4 Causing Hepatitis-Hydropericardium Syndrome and FAdV-8b/-11 Causing Inclusion Body Hepatitis 